Don’t miss outtag icon
Get early access to Digital 100 2026, Similarweb’s official ranking of the fastest-growing brandsPre-register now!banner icon
Adverum

November 2025

Adverum Market Share Analysis for November 2025

At Adverum, we are driven to establish ocular gene therapy as a new standard of care for debilitating retinal diseases.
Year Founded2006
Employees51 - 200
Annual Revenue$2M - $5M
adverum.com
Adverum
Adverum (including company regionals)
  • adverum.com
    adverum.com
See more website traffic and engagement information

Adverum Revenue up to November 2025 is 2M - 5M

revenue generated by Adverum top domains

Adverum top domains revenue over 3 years

Revenue for Adverum top domains


Total visits to Adverum's top domains

Understand Adverum market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Adverum's top domains

Analyze Adverum engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Adverum's top domains

See how Adverum keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Adverum

These are the website technologies, by industry, used by Adverum top domains

Payment & Currencies (8)

Cart Functionality

Cart Functionality

Widget (6)

Twemoji

Twemoji

Advertising (2)

PubMatic

PubMatic

Content Management System (2)

WordPress

WordPress

More Technologies

9

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Adverum

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAdverum Biotechnologies, Inc. is developing genetic medicines for sight-threatening eye diseases.Adverum, formerly named Avalanche Biotechnologies, has been working for nearly two decades to develop genetic medicines for sight-threatening eye diseases.
NewsEli Lilly was planning to acquire Adverum Biotechnologies, Inc. on Oct 24th '25.Today Lilly announced that it is acquiring Adverum Biotechnologies.
NewsAdverum Biotechnologies, Inc. is developing ixoberogene soroparvovec (Ixo-vec.Adverum is developing ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022), its clinical-stage gene therapy product candidate, for the treatment of wet AMD.

See all Adverum signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.